(0.26%) 5 113.13 points
(0.24%) 38 333 points
(0.26%) 15 969 points
(-1.38%) $82.69
(4.32%) $2.01
(0.04%) $2 348.10
(-0.12%) $27.50
(3.72%) $956.40
(-0.18%) $0.933
(-0.27%) $10.99
(-0.47%) $0.797
(1.76%) $93.49
0.98% HKD 12.38
Live Chart Being Loaded With Signals
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments...
Stats | |
---|---|
Tagesvolumen | 4.96M |
Durchschnittsvolumen | 3.25M |
Marktkapitalisierung | 60.48B |
EPS | HKD0.186 ( 2023-09-30 ) |
Last Dividend | HKD0.460 ( 2023-07-31 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 12.90 |
ATR14 | HKD0.0150 (0.12%) |
Volumen Korrelation
Shanghai Fosun Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Shanghai Fosun Korrelation - Währung/Rohstoff
Shanghai Fosun Finanzdaten
Annual | 2023 |
Umsatz: | HKD41.40B |
Bruttogewinn: | HKD19.80B (47.84 %) |
EPS: | HKD0.890 |
FY | 2023 |
Umsatz: | HKD41.40B |
Bruttogewinn: | HKD19.80B (47.84 %) |
EPS: | HKD0.890 |
FY | 2022 |
Umsatz: | HKD43.95B |
Bruttogewinn: | HKD20.78B (47.28 %) |
EPS: | HKD1.430 |
FY | 2021 |
Umsatz: | HKD39.01B |
Bruttogewinn: | HKD18.78B (48.14 %) |
EPS: | HKD1.850 |
Financial Reports:
No articles found.
Shanghai Fosun Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.460 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.210 | 2013-07-04 |
Last Dividend | HKD0.460 | 2023-07-31 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 11 | -- |
Total Paid Out | HKD4.51 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.42 | -- |
Div. Sustainability Score | 7.35 | |
Div.Growth Potential Score | 4.70 | |
Div. Directional Score | 6.03 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
9909.HK | Ex Dividend Knight | 2023-11-24 | Semi-Annually | 0 | 0.00% | |
2161.HK | Ex Dividend Junior | 2023-08-15 | Annually | 0 | 0.00% | |
1161.HK | Ex Dividend Knight | 2023-06-12 | Annually | 0 | 0.00% | |
0239.HK | Ex Dividend Knight | 2023-09-29 | Semi-Annually | 0 | 0.00% | |
3866.HK | Ex Dividend Junior | 2023-06-02 | Annually | 0 | 0.00% | |
1731.HK | Ex Dividend Junior | 2023-06-23 | Sporadic | 0 | 0.00% | |
0771.HK | Ex Dividend Junior | 2023-05-31 | Sporadic | 0 | 0.00% | |
2327.HK | Ex Dividend Junior | 2023-08-03 | Sporadic | 0 | 0.00% | |
1290.HK | Ex Dividend Junior | 2023-06-14 | Sporadic | 0 | 0.00% | |
0363.HK | Ex Dividend Knight | 2023-06-01 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0576 | 1.500 | 8.85 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0210 | 1.200 | 9.30 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0523 | 1.500 | -0.530 | -0.795 | [0.1 - 1] |
payoutRatioTTM | 1.029 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 1.001 | 0.800 | 9.99 | 8.00 | [1 - 3] |
quickRatioTTM | 0.757 | 0.800 | -0.254 | -0.203 | [0.8 - 2.5] |
cashRatioTTM | 0.406 | 1.500 | 8.86 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.309 | -1.500 | 4.84 | -7.26 | [0 - 0.6] |
interestCoverageTTM | 2.50 | 1.000 | -0.186 | -0.186 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.173 | 2.00 | 9.61 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | -0.601 | 2.00 | -0.301 | -0.601 | [0 - 20] |
debtEquityRatioTTM | 0.769 | -1.500 | 6.93 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.478 | 1.000 | 5.36 | 5.36 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0799 | 1.000 | -0.402 | -0.402 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.100 | 1.000 | -0.553 | -0.553 | [0.2 - 2] |
assetTurnoverTTM | 0.365 | 0.800 | -0.901 | -0.721 | [0.5 - 2] |
Total Score | 7.35 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 14.55 | 1.000 | 8.63 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0523 | 2.50 | -0.341 | -0.795 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.601 | 2.00 | -0.200 | -0.601 | [0 - 30] |
dividendYielPercentageTTM | 3.98 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.173 | 2.00 | 9.61 | 10.00 | [0 - 30] |
payoutRatioTTM | 1.029 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | 6.62 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0852 | 1.000 | -0.370 | 0 | [0.1 - 0.5] |
Total Score | 4.70 |
Shanghai Fosun
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, metabolism, alimentary and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.